The role of 13N-ammonia in the differential diagnosis of gliomas and brain inflammatory lesions

[1] Hervey-Jumper SL(2016)Maximizing safe resection of low- and high-grade glioma J Neurooncol 130 269-282

[2] Berger MS(2015)Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients Neuro Oncol 17 784-800

[3] Hutterer M(2016)High-grade glioma management and response assessment-recent advances and current challenges Curr Oncol 23 e383-e391

[4] Hattingen E(2013)Pseudoprogression in high-grade glioma Acta Neurol Scand Suppl 127 31-37

[5] Palm C(2015)From the clinician’s point of view—what is the status quo of positron emission tomography in patients with brain tumors? Neuro Oncol 17 1434-1444

[6] Proescholdt MA(2015)PET, MRI, and simultaneous PET/MRI in the development of diagnostic and therapeutic strategies for glioma Drug Discov Today 20 306-317

[7] Hau P(2013)Diagnostic accuracy of PET for recurrent glioma diagnosis: a meta-analysis AJNR Am J Neuroradiol 34 944-950

[8] Khan MN(2010)11C-methionine positron emission tomography in nontumorous brain lesions No ShinkeiGeka 38 985-995

[9] Sharma AM(2014)Applications of positron emission tomography in neuro-oncology: a clinical approach Surgeon 12 148-157

[10] Pitz M(2006)Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas Eur J Nucl Med Mol Imaging 33 516-524

[1] Hervey-Jumper SL(2016)Maximizing safe resection of low- and high-grade glioma J Neurooncol 130 269-282

[2] Berger MS(2015)Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients Neuro Oncol 17 784-800

[3] Hutterer M(2016)High-grade glioma management and response assessment-recent advances and current challenges Curr Oncol 23 e383-e391

[4] Hattingen E(2013)Pseudoprogression in high-grade glioma Acta Neurol Scand Suppl 127 31-37

[5] Palm C(2015)From the clinician’s point of view—what is the status quo of positron emission tomography in patients with brain tumors? Neuro Oncol 17 1434-1444

[6] Proescholdt MA(2015)PET, MRI, and simultaneous PET/MRI in the development of diagnostic and therapeutic strategies for glioma Drug Discov Today 20 306-317

[7] Hau P(2013)Diagnostic accuracy of PET for recurrent glioma diagnosis: a meta-analysis AJNR Am J Neuroradiol 34 944-950

[8] Khan MN(2010)11C-methionine positron emission tomography in nontumorous brain lesions No ShinkeiGeka 38 985-995

[9] Sharma AM(2014)Applications of positron emission tomography in neuro-oncology: a clinical approach Surgeon 12 148-157

[10] Pitz M(2006)Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas Eur J Nucl Med Mol Imaging 33 516-524